Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.
about
The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancerProkineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv.
P2860
Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Anti-prokineticin1 (PROK1) mon ...... r growth in colorectal cancer.
@en
Anti-prokineticin1
@nl
type
label
Anti-prokineticin1 (PROK1) mon ...... r growth in colorectal cancer.
@en
Anti-prokineticin1
@nl
prefLabel
Anti-prokineticin1 (PROK1) mon ...... r growth in colorectal cancer.
@en
Anti-prokineticin1
@nl
P2093
P2860
P1476
Anti-prokineticin1 (PROK1) mon ...... r growth in colorectal cancer.
@en
P2093
Akio Yamaguchi
Takanori Goi
Toshiyuki Nakazawa
Yasuo Hirono
P2860
P2888
P304
P356
10.1245/S10434-014-3765-8
P478
21 Suppl 4
P577
2014-05-17T00:00:00Z
P6179
1020231638